Skip to content

Email alerts to mitigate evidence contamination in systematic reviews: a two-stage randomized controlled trial with sequential escalated interventions

Email alerts to mitigate evidence contamination in systematic reviews: a two-stage randomized controlled trial with sequential escalated interventions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121388
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-07
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental Group 1:Email notification to editors in Phase 1 and an escalated intervention will be employed to send the email to their authors in Phase 2
Experimental Group 2:Email notification to authors in Phase 1 and an escalated intervention will be employed to send the email to their editors in Phase 2
Group 3 Control Group:No interventions in Phase 1 and an escalated intervention will be employed to send the email to both editors and authors in Phase 2

Sponsors

Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We will identify eligible SRs (contaminated SRs) that meet all of the following inclusion criteria: 1.SRs that synthesize at least one retracted trial in evidence synthesis; 2.SRs focused on healthcare interventions; 3.No correction action regarding the retracted trials prior to randomization, such as correction, and updating; 4.Updated version remaining to synthesize retracted trials (e.g., Cochrane reviews).

Exclusion criteria

Exclusion criteria: And, contaminated SRs will be excluded if reviews meet any of the exclusion criteria: 1.SRs themselves have been retracted; 2.Retracted trials having been removed in the latest version of targeted SRs and conclusion having been updated accordingly; 3.SRs labelled as an expression of concern by editors; 4.Evidence used for meta-regression analysis and other reproducibility study (e.g., umbrella reviews), due to burden of replication to these studies; 5.SRs published on pre-print websites (e.g., medRxiv); 6.SRs published in non-English languages; 7.SRs published as short reports or conference abstracts.

Design outcomes

Primary

MeasureTime frame
The primary outcome is a composite endpoint comprising correction, update, and retraction of SRs. ;

Secondary

MeasureTime frame
Correction for flawed evidence from retarcted trials;Updates to flawed evidence from retarcted trials;Retraction of systematic reviews;Time to expression of concerns;Response rate to emails;Censoring for repair contamination after removal of flawed evidence:;

Countries

China

Contacts

Public ContactZhen Peng

Anhui Medical University

wspzwd@163.com+86 157 0569 6938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026